BDBM50185092 2-(4-methylbenzamido)-4,5,6,7-tetrahydrobenzo[b]thiophene-3-carboxamide::CHEMBL209285
SMILES: Cc1ccc(cc1)C(=O)Nc1sc2CCCCc2c1C(N)=O
InChI Key: InChIKey=WLJRTUWMOKECEF-UHFFFAOYSA-N
Data: 1 IC50
Target/Host (Institution) | Ligand | Target/Host Links | Ligand Links | Trg + Lig Links | Ki nM | ΔG° kcal/mole | IC50 nM | Kd nM | EC50/IC50 nM | koff s-1 | kon M-1s-1 | pH | Temp °C |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Receptor-type tyrosine-protein kinase FLT3 (Homo sapiens (Human)) | BDBM50185092 (2-(4-methylbenzamido)-4,5,6,7-tetrahydrobenzo[b]th...) | PDB MMDB KEGG UniProtKB/SwissProt B.MOAD DrugBank antibodypedia GoogleScholar AffyNet | Purchase CHEMBL PC cid PC sid UniChem Patents Similars | Article PubMed | n/a | n/a | 52 | n/a | n/a | n/a | n/a | n/a | n/a |
Johnson & Johnson Pharmaceutical Research and Development Curated by ChEMBL | Assay Description Inhibition of FLT3 | Bioorg Med Chem Lett 16: 3282-6 (2006) Article DOI: 10.1016/j.bmcl.2006.03.032 BindingDB Entry DOI: 10.7270/Q2R49QCV | |||||||||||
More data for this Ligand-Target Pair |